John W. Varian
Independent Chairman of BoardMr. John W. Varian serves as an Independent Director at Acorda Therapeutics, Inc. since January 1, 2022. He serves as Independent Director of SELLAS Life Sciences Group, Inc. since December 2017 and serves as its Chairman of Board since June 2024. He has been Director of AmMax Bio Inc. He served as a Director of Egalet Corporation since June 7, 2018 until January 31, 2019. Mr. Varian served as Director of Versartis, Inc. since March 2014 until October 12, 2018. Mr. Varian served as the Chief Executive Officer of XOMA Corporation from August 2011 to December 21, 2016. Mr. Varian served as an Interim Chief Executive Officer of XOMA Corporation from August 31, 2011 to January 5, 2012. Mr. Varian served as the Chief Operating Officer of ARYx Therapeutics Inc. from December 2003 to August 2011. Mr. Varian served as Chief Financial Officer of ARYx Therapeutics, Inc. from April 2006 to March 10, 2011. Mr. Varian served as a Vice President of Aryx Therapeutics Inc. He served as the Chief Financial Officer and Interim Chief Financial Officer of Deltagen Inc. since April 21, 2003. Beginning in May 2000, Mr. Varian served as the Chief Financial Officer of Genset S.A. from May 2000 to 2002. Mr. Varian served as Vice President and Chief Financial Officer of Neurex corporation from June 1997 to October 1998. During his tenure at Neurex, he was responsible for enhancing its visibility with Wall Street and the pharmaceutical industry. He is employed at Serono Genetics Institute S.A. From 1998 to 2000, he served as Senior Vice President of Finance and Administration at Elan Pharmaceuticals, Inc. He was appointed to that position in 1998 when Elan Corp. acquired Neurex, Inc., where he served as Chief Financial Officer since 1997. From 1991 to 1997, Mr. Varian served as the Vice President of Finance and Chief Financial Officer of Anergen Inc. He worked as a certified public accountant, including as an Audit Principal and Senior Manager in the San Francisco office of Ernst & Young LLP from 1987 until 1991 where he focused on life sciences. He served as a Director of XOMA Corporation since December 8, 2008 until May 24, 2017. Mr. Varian served as a Director of Nventa Biopharmaceuticals Corporation since May 2008. He is a founding Member of the Bay Area Bioscience Center and served as Chairman of the Association of Bioscience Financial Officers International Conference. He has been a frequent guest lecturer for various universities, including University of California, Berkeley, University of California, Santa Barbara and California Polytechnic State University. He is a Certified Public Accountant. Mr. Varian holds a BBA degree from Western Michigan University.
Positions
- Company NameSELLAS Life Sciences Group, Inc.Stock CodeSLSPositionIndependent Chairman of BoardColleagues
- AMAngelos M. StergiouFounder, President, CEO & Director
- JTJohn Thomas BurnsSenior VP & CFO
- DCDragan CicicSenior VP & Chief Development Officer
- SEStacy E. YeungVP, General Counsel & Corporate Secretary
- AEAndrew ElnatanSenior VP of Regulatory Affairs, CMC & Quality
- JWJane WasmanIndependent Director
- RLRobert L. Van NostrandIndependent Director
- KBKatherine Bach KalinIndependent Director
